/ 11 Shares
12-Dec-2024 - 16-Dec-2024
₹ 1265 - ₹ 1329
₹ 14619.00
11
18,730,510
Face Value - ₹ 1/- Per Share
Listing at NSE BSE
170,277 Application Required in Retail for 1 Time.
Registrar : Link Intime India Private Ltd
Offer for Sale of upto 18,795,510 Equity Shares
Category | % | Shares/Amount |
---|---|---|
QIB | 75% | 14,047,882 Shares RS.1866.95 CR |
HNI 1 | 5% | 936,526 Shares RS.124.46 CR @ 6081 FORM 1X |
HNI 2 | 10% | 1,873,051 Shares RS.248.93 CR @ 12163 FORM 1X |
Retail | 10% | 1,873,050 Shares RS.248.93 CR @ 170277 FORM 1X |
BRLMs: ICICI Securities, Jefferies India, JM Financial, J.P.Morgan India, Nomura Financial
Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
---|---|---|
170277 FORM 1X | 6081 FORM 1X | 12163 FORM 1X |
Category | Lots | Shares | Amount |
---|---|---|---|
Retail (Upto 2 Lakh) | 1 | 11 | ₹ 14,619 |
Retail (Upto 2 Lakh) | 13 | 143 | ₹ 190,047 |
S-HNI (2 Lakh to 10 Lakh) | 14 | 154 | ₹ 204,666 |
S-HNI (2 Lakh to 10 Lakh) | 68 | 748 | ₹ 994,092 |
B-HNI (Above 10 Lakh) | 69 | 759 | ₹ 1,008,711 |
16-Dec-2024 19:09
Category | Book Size | Subscription | No. of Times |
---|---|---|---|
QIB | 5,619,154 ₹ 746.79 Cr. | 453,155,846 ₹ 60224.41 Cr. | 80.64x |
HNI (<10 LAKH) | 936,526 ₹ 124.46 Cr. | 18,562,698 ₹ 2466.98 Cr. | 19.82x |
HNI2 (>10 LAKH) | 1,873,051 ₹ 248.93 Cr. | 46,814,878 ₹ 6221.70 Cr. | 24.99x |
RETAIL | 1,873,050 ₹ 248.93 Cr. | 27,448,322 ₹ 3647.88 Cr. | 14.65x |
Total | 10,301,781 | 545,981,744 | 53.00x |
Category | Book Size | Subscription | No. of Times |
---|---|---|---|
QIB | 5,619,154 ₹ 746.79 Cr. | 453,155,846 ₹ 60224.41 Cr. | 80.64x |
HNI (<10 LAKH) | 936,526 ₹ 124.46 Cr. | 18,562,698 ₹ 2466.98 Cr. | 19.82x |
HNI2 (>10 LAKH) | 1,873,051 ₹ 248.93 Cr. | 46,814,878 ₹ 6221.70 Cr. | 24.99x |
RETAIL | 1,873,050 ₹ 248.93 Cr. | 27,448,322 ₹ 3647.88 Cr. | 14.65x |
Total | 10,301,781 | 545,981,744 | 53.00x |
*Excluding Anchor
Total No. of Application Approx : ~2960800 (17.39 Appwise)
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
Inventurus Knowledge Solutions (“IKS”) was incorporated on September 5, 2006. IKS is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. They are a leading partner for outpatient and inpatient care organizations, enabling healthcare organizations deliver superior clinical care, improve population health outcomes, and transition to the “fee for value” model while optimizing their revenue and reducing operating costs. The company provides solutions that address these increasing tasks, or 'chores', and enable healthcare delivery enterprises to focus on their core focus of healthcare, by taking over chores that are necessary to manage their business. They offer a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care.
As of September 30, 2024, IKS has over 778 healthcare organizations as their clients, including health systems, academic medical centres, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations and other outpatient and inpatient healthcare delivery organizations.
Some of the key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.
As of September 30, 2024, they serve their clients through their consolidated globalized workforce of over 13,528 employees, including 2,612 clinically trained employees and a consultative sales force with presence in key geographies in the US, Canada and Australia.
Company’s services enable healthcare organizations to deliver superior clinical care, improve population health outcomes, and transition to the “Fee for Value” model while optimizing their revenue and reducing operating costs.
IKS offers digital health platform that help their clients build, enhance, maintain, support, and manage their technology systems better. In addition, company’s Unifying Data Platform (“UDP”) allows clients to aggregate data from multiple billing systems, electronic health records (“EHR”), and clearing houses to obtain a single informational database for effective decision-making.
IKS acquired Aquity Holdings, a company engaged in technology-enabled clinical documentation, medical coding and revenue integrity solutions for healthcare. Through the acquisition of Aquity Holdings with effect from October 27, 2023, they are able to cross-sell to Aquity's existing base of over 804 customers, as of March 31, 2024, and offer existing solutions to this customer base, thereby increasing their market opportunity.
Competitive Strength
Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations;
Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered;
Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions;
Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 90% in the last 3 Fiscals;
Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch;
Healthy financial performance with growth and improving margins;
Experienced and entrepreneurial driven leadership team.
Business Strategies
Maximise revenue from existing clients through a “land and expand” approach;
Focus on large healthcare organizations;
Move from a “human-led tech-enabled” model to a “tech-led human-enabled” model;
Bundling solutions for greater value-add;
Leverage automation and Generative Artificial Intelligence (AI) to aid the operations;
Partner with innovative clients for product development and innovation;
Develop solutions to address the needs of entities moving to “Value-Based Care”
Inventurus Knowledge Solutions Limited's revenue increased by 75.25% and profit after tax (PAT) rose by 21.38% between the financial year ending with March 31, 2024 and March 31, 2023.
Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 2,790.52 | 3,027.52 | 988.31 | 787.52 |
Revenue | 1,294.61 | 1,857.94 | 1,060.16 | 784.47 |
Profit After Tax | 208.58 | 370.49 | 305.23 | 232.97 |
Net Worth | 1,377.11 | 1,157.86 | 828.64 | 647.07 |
Reserves and Surplus | 1,360.17 | 1,140.94 | 811.80 | 630.26 |
Total Borrowing | 828.63 | 1,193.42 | ||
Amount in ? Crore |
The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.
Once you create your account, Login to InvestoYard.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.